This establishes the importance of ensuring quality of diagnostic tests in clinical management of patients.
Health technology scientifically augments the evolutionary journey of effective delivery of healthcare. Featured technology, incorporated in medical devices and diagnostic platforms can aid in the improving patient outcomes.
iQM, the revolutionary tool for comprehensive quality assurance of ABG test results, is one significant illustration of how health technology can provide an enormous amount of reliable and clinically useful information that can be derived from a vital test parameter like ABG for better patient management.
The GEM family of analysers were introduced long back in India and iQM has been into utilisation as one of the key features for these analysers. With increasing focus on quality assurance and in line with business objectives, it became imperative to project and leverage this incredible technological feature, starting with the awareness (re)creation within the ecosystem.
The best way to start a massive campaign is to begin it on a high note and with high first impact. So, Dr James Westgard, the foremost authority on QC, and his son Stan were chosen as expert speakers with immense support from EEMEAI stakeholders. To give the event an unparalleled credibility, the collaboration of National Accreditation Board for testing and calibrations Laboratories (NABL), the highest body of accreditation in India, was ensured with the CEO of NABL been ascribed the role of chairperson for the event. To ensure adequate and appropriate representation of Indian stakeholders, key users and ardent ambassadors of Quality assurance were selected as speakers. Finally, to keep up the element of real-life scenario and to address the major doubts, challenges and queries, a panel discussion was conducted in the end.
This event saw many firsts. From the company side, almost every person from sales, application and service teams were involved in campaigning for the event. From the ecosystem side, laboratory doctors and prescribers, technicians, nurses, intensivists, biomedical engineers, distributors, purchase professionals, administrators and policy makers (NABL officials) were all encouraged to enrol as participants. From the Indian healthcare system perspective, this was the first event that focused on positively impacting the perception and implementation of Quality Assurance Program in the country. As a result, there were 1425 total registrations out of which 581 eventually attended the session, both of which are a record for Werfen in India.
This is certainly one industry hosted event that has given a new insight to the ecosystem and, for sure, has provided just the right stimulus to shift the focus on quality assurance at point of care. For the company, this has become a substantial platform to incorporate the potential of iQM within the value selling fundamentals to build on the momentum and establish it as a key differentiator from the competition.
Werfen India Team



